Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernhard Gerber

Showing results (71-80 of 138) with videos related to

Pageof 14
Sort By:
ESC Heart Failure|January 21, 2022
Eyes on amyloidosis: microvascular retinal dysfunction in cardiac amyloidosisEmanuel Zampiccoli, Jens Barthelmes, Leonie Kreysing, et al.
British Journal of Haematology|May 6, 2021
A universal anti-Xa assay for rivaroxaban, apixaban, and edoxaban measurements: method validation, diagnostic accuracy and external validationGuido Willekens, Jan-Dirk Studt, Adriana Mendez, et al.
Leukemia & Lymphoma|August 22, 2018
Efficacy of selective digestive decontamination in patients with multiple myeloma undergoing high-dose chemotherapy and autologous stem cell transplantationCéline M Mürner, Frank Stenner-Liewen, Burkhardt Seifert, et al.
Platelets|May 9, 2023
Mean platelet volume: a prognostic marker in heart failure with preserved ejection fractionNassiba Menghoum, Christophe Beauloye, Sibille Lejeune, et al.
Cancer Epidemiology|January 6, 2017
Trends of classification, incidence, mortality, and survival of MDS patients in Switzerland between 2001 and 2012Nicolas Bonadies, Anita Feller, Alicia Rovo, et al.
Frontiers in Cardiovascular Medicine|September 27, 2021
Automated Thrombin Generation Assay for Rivaroxaban, Apixaban, and Edoxaban MeasurementsTamana Meihandoest, Jan-Dirk Studt, Adriana Mendez, et al.
Swiss Medical Weekly|April 6, 2023
Acquired haemophilia A in southern Switzerland from 2013 to 2019: a case seriesAndrea Ruberti, Johanna A Kremer Hovinga, Federico Nappi, et al.
Trials|September 10, 2020
Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trialStefano Barco, Roland Bingisser, Giuseppe Colucci, et al.
Diagnostics (Basel, Switzerland)|June 28, 2023
Determination of Anti-Xa Inhibitor Plasma Concentrations Using a Universal Edoxaban CalibratorAnnika Burger, Jan-Dirk Studt, Adriana Mendez, et al.
European Heart Journal. Cardiovascular Imaging|November 17, 2025
Lipoprotein(a) and long-term structural valve degeneration of aortic bioprosthesesMarin Boute, Paul Salembier, Anne-Catherine Pouleur, et al.
Pageof 14

Showing results (71-80 of 138) with videos related to

Sort By:
Pageof 14
ESC Heart Failure|January 21, 2022
Eyes on amyloidosis: microvascular retinal dysfunction in cardiac amyloidosisEmanuel Zampiccoli, Jens Barthelmes, Leonie Kreysing, et al.
British Journal of Haematology|May 6, 2021
A universal anti-Xa assay for rivaroxaban, apixaban, and edoxaban measurements: method validation, diagnostic accuracy and external validationGuido Willekens, Jan-Dirk Studt, Adriana Mendez, et al.
Leukemia & Lymphoma|August 22, 2018
Efficacy of selective digestive decontamination in patients with multiple myeloma undergoing high-dose chemotherapy and autologous stem cell transplantationCéline M Mürner, Frank Stenner-Liewen, Burkhardt Seifert, et al.
Platelets|May 9, 2023
Mean platelet volume: a prognostic marker in heart failure with preserved ejection fractionNassiba Menghoum, Christophe Beauloye, Sibille Lejeune, et al.
Cancer Epidemiology|January 6, 2017
Trends of classification, incidence, mortality, and survival of MDS patients in Switzerland between 2001 and 2012Nicolas Bonadies, Anita Feller, Alicia Rovo, et al.
Frontiers in Cardiovascular Medicine|September 27, 2021
Automated Thrombin Generation Assay for Rivaroxaban, Apixaban, and Edoxaban MeasurementsTamana Meihandoest, Jan-Dirk Studt, Adriana Mendez, et al.
Swiss Medical Weekly|April 6, 2023
Acquired haemophilia A in southern Switzerland from 2013 to 2019: a case seriesAndrea Ruberti, Johanna A Kremer Hovinga, Federico Nappi, et al.
Trials|September 10, 2020
Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trialStefano Barco, Roland Bingisser, Giuseppe Colucci, et al.
Diagnostics (Basel, Switzerland)|June 28, 2023
Determination of Anti-Xa Inhibitor Plasma Concentrations Using a Universal Edoxaban CalibratorAnnika Burger, Jan-Dirk Studt, Adriana Mendez, et al.
European Heart Journal. Cardiovascular Imaging|November 17, 2025
Lipoprotein(a) and long-term structural valve degeneration of aortic bioprosthesesMarin Boute, Paul Salembier, Anne-Catherine Pouleur, et al.
Pageof 14